We have tested our revised Sel-MQC-CSI sequence for dependence of Lac/H2O on the B0 and B1 field inhomogeneity. The immunity of the Lac/H2O from our sequence on the above factors was demonstrated. We have improved lipid suppression from previously reported 100-fold to 22,000-fold while not losing the lactate signal. The revised sequence was applied to a glioma patient and a normal volunteer with a lactate phantom seated near the typical lymphoma occurring region of the body. In both human studies, satisfactory performance of the sequence was demonstrated.
This abstract and the presentation materials are available to members only; a login is required.